Certara Announces Participation in Notable Investor Events
Certara to Engage Investors in Key Conferences
Certara, Inc. (NASDAQ: CERT), a leading global company in model-informed drug development, has exciting news for investors. The company has announced its participation in prestigious investor conferences designed to showcase its advancements and foster investment opportunities.
Upcoming Conferences
Certara's management team will be present at the following notable events:
UBS Global Healthcare Conference
On Tuesday, November 11, Certara will take the stage at 2:00 PM ET to share insights with investors at the UBS Global Healthcare Conference.
Jefferies Global Healthcare Conference
On Tuesday, November 18, Certara will also participate in the Jefferies Global Healthcare Conference held in London, scheduled for 10:30 AM GMT.
Stephens Annual Investment Conference
Additionally, those interested can catch Certara on the same day, November 18, during the Stephens Annual Investment Conference at 1:00 PM CT.
Access to Live Webcasts
Investors eager to follow the discussions can access live webcasts for each conference through Certara's investor relations platform, which will be available with replays for at least 90 days afterward.
Understanding Certara's Impact
Certara’s mission involves accelerating the process of drug development utilizing advanced biosimulation software and technology. With its innovative approach, Certara collaborates with over 2,400 clients, including biopharmaceutical companies, research institutions, and regulatory entities in more than 70 countries. This wide-reaching network helps shape the future of drug discovery, making it significantly more efficient and effective.
Investor Relations Contact
For any inquiries related to investor relations, reach out to David Deuchler from Gilmartin Group. He will be happy to assist and provide additional insights into Certara's robust strategies.
Contact: ir@certara.com
Media Contact for More Information
For media inquiries, Alyssa Horowitz is available for comments and further information. An engaged media presence helps shine a light on Certara’s innovative contributions to the healthcare industry.
Contact: certara@pancomm.com
Frequently Asked Questions
What is Certara known for?
Certara is renowned for its pioneering role in model-informed drug development, utilizing advanced biosimulation technologies.
When are the upcoming investor conferences?
The conferences are scheduled for November 11 and 18, where Certara's management will present their insights.
How can I access the live conferences?
Live webcasts will be accessible through Certara's investor relations website, with recordings available for 90 days.
What industries does Certara serve?
Certara caters to biopharmaceutical companies, academic institutions, and regulatory agencies worldwide.
Who do I contact for investor relations inquiries?
For inquiries, you can contact David Deuchler at ir@certara.com.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
